SCHEMBL4356156

SCHEMBL4356156

COc1ccc2cc(/C=C3\SC(N4CCN(c5ccccc5)CC4)=NC3=O)ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.64
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
MCHR1 Q99705 1/20 0.58
MAPT P10636 6/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 3/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.56
GRIN1 Q05586 1/20 0.55
GRIN2B Q13224 1/20 0.55
SENP1 Q9P0U3 1/20 0.55
POLB P06746 3/20 0.54
ALOX5 P09917 3/20 0.54
KDM4E B2RXH2 1/20 0.52
GAA P10253 1/20 0.52
ENPP2 Q13822 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356157 1.00 DCTPP1 (0.64) DCTPP1MEN1KMT2ANPC1RAB9A
SCHEMBL4352350 0.88 GRIN1 (0.73) MEN1KMT2ANPC1RAB9AMCHR1
SCHEMBL4352346 0.88 GRIN1 (0.73) MEN1KMT2ANPC1RAB9AMCHR1
SCHEMBL4355372 0.83 GRIN1 (0.78) DCTPP1MEN1KMT2AMCHR1MAPT
SCHEMBL4355367 0.83 GRIN1 (0.78) DCTPP1MEN1KMT2AMCHR1MAPT
SCHEMBL4357485 0.80 DCTPP1 (0.78) DCTPP1MEN1KMT2ARAB9AMAPT
SCHEMBL4357487 0.80 DCTPP1 (0.78) DCTPP1MEN1KMT2ARAB9AMAPT
SCHEMBL4354290 0.79 MAPT (0.66) DCTPP1MEN1KMT2ANPC1RAB9A
SCHEMBL4359063 0.78 MAPT (0.69) DCTPP1MEN1KMT2ANPC1RAB9A
SCHEMBL4348473 0.78 DCTPP1 (0.78) DCTPP1MEN1KMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 DCTPP1 167/4885MEN1 1725/4885KMT2A 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.